Skip to main content
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 2010 Mar 29;19(6):1272–1278. doi: 10.1002/pro.391

Similarities between Argonautes and the alpha-sarcin-like ribotoxins: Implications for microRNA action

Edward Pichinuk 1, Daniel H Wreschner 1,*
PMCID: PMC2895252  PMID: 20512980

Abstract

We report structural, functional, and biochemical similarities between Argonautes, the effector proteins of RNA-induced silencing complexes (RISCs), and alpha-sarcin-like ribotoxins. At the structural level, regions of similarity in the amino acid sequence are located in protein loops both in the ribotoxins and in the Argonautes. In ribotoxins, these protein loops confer specificity for a highly conserved segment of ribosomal RNA, the Sarcin-Ricin-Loop (SRL) that undergoes cleavage by the ribotoxin ribonuclease. This leads to suppression of translation. In addition to the structural similarity with ribotoxins, the Argonaute proteins (Ago) show both functional and biochemical parallels. Like the ribotoxins, the Agos exhibit ribonuclease activity and like the ribotoxins, translational suppression mediated by miRISC-resident Ago is accompanied by intact polysomes. Furthermore, in both translationally suppressed systems, the puromycin reaction, reflecting correct translocation and peptidyl-transferase activities, is unharmed. These findings support a mechanism for Ago-miRISCs whereby regulated cleavage of ribosomal RNA leads to translational suppression.

Keywords: ribotoxins, argonaute proteins, SRL, miRNA, translational suppression, alpha-sarcin, rRNA cleavage

Introduction

Ribotoxins, alpha-sarcin representing one class and ricin another, potently suppress translation at the elongation stage by cleaving a specific site within the large 28S rRNA component of the 60S ribosomal subunit.13 The extraordinary specificity of these toxins is restricted to one cleavage site within the 7000 or so nucleotides. The alpha-sarcin-like ribotoxins cleave3 the phosphodiester bond on the 3′ side of G4325 in 28S rRNA, generating a distinctive 3′ α-fragment. The ricin-like ribotoxins depurinate the A4324 residue immediately upstream of the site of α-sarcin- mediated cleavage.4,5 These cleavage sites are located within a ribosomal RNA loop, designated the sarcin-ricin-loop or SRL.3,69 Cleavage by alpha-sarcin-like ribotoxins or depurination by the ricin-like toxins accounts for their toxicity and ribosome-inactivating activity. The SRL includes some 20 nucleotides and is the most conserved region7 in both 28S rRNA and bacterial 23S rRNA, showing sequence conservation from bacteria, through worms to humans.

The Argonaute (Ago) proteins, like the ribotoxins, also inhibit protein synthesis [for recent reviews, see Refs. 1012]. In contrast to the ribotoxins, they are an endogenous set of proteins and represent the principal effectors of protein synthesis inhibition mediated by both short interfering RNA (siRNA) and microRNA (miRNAs).

Intriguingly, like the ribotoxins, the Ago proteins also possess endoribonucleolytic activity. This has been extensively documented for the Ago2 protein,13,14 the executor component of RNA-Induced-Silencing-Complexes (RISCs), consisting of siRNAs (siRISCs). For siRISC-mediated translational inhibition, full complementarity between the siRNA and target mRNAs leads to cleavage of mRNA mediated by the Ago Slicer ribonuclease. In the absence of complete complementarity between the mRNA target and translational miRNA, suppression mediated by miRNA-containing RISCs, does not involve direct cleavage of mRNA. Although originally not considered a ribonuclease, Ago1, the critical component of miRISC-mediated translational suppression, has recently been shown to also possess ribonuclease activity.15 These findings suggest that like Ago2, the ribonucleolytic activity of Ago1 may be vital for translational suppression mediated by miRISCs. However, the mechanism of action of miRISCs in translational suppression remains enigmatic.

The puzzle in translational suppression mediated by miRISCs stems principally from the fact that despite extensive homology between the Ago1 protein of miRISCs and the Slicer Ago2 protein of siRISCs, and notwithstanding the recently documented Ago1 ribonucleolytic activity, miRISCs, unlike the siRISCs, do not directly mediate mRNA cleavage.

As for the alpha-sarcin-like ribotoxins, they potently suppress translation and possess ribonucleolytic activity, yet the inhibition they exert is not accompanied by mRNA cleavage.

These likenesses in translational suppression mediated by alpha-sarcin-like ribotoxins and miRISCs prompted us to investigate whether there are similarities in the molecular make-up of the Ago proteins and the ribotoxins. We show here a marked similarity between these seemingly diverse groups of proteins. Intriguingly the homology is localized to regions of the ribotoxins responsible for their binding to the critical Sarcin-Ricin-Loop, subsequently cleaved by the ribotoxin. Additionally, a review of the literature reveals a paradoxically intact puromycin reaction, observed not only in ribosomes translationally suppressed by alpha-sarcin-like ribotoxins but also in ribosomes suppressed by miRISCs. Because of these common features, our findings indicate that translational suppression mediated by alpha-sarcin-like ribotoxins and the Argonaute proteins making up the miRISCs share a similar mechanism of action.

Results and Discussion

Sequence similarity between alpha-sarcin-like ribotoxins and Argonaute proteins-localization in protein loops recognizing the SRL

Ribotoxins contain motifs determining a structural core common to other ribonucleases, and especially T1-like ribonucleases. As distinct from the T1 ribonucleases, ribotoxins include extra protein domains that have been proposed to be naturally genetically engineered onto the T1 RNAse skeleton.16,17 These domains typically form large loops numbered 1 through 5 (Figs. 1 and 2). The loop-like elements of the ribotoxins direct the RNAse component of the ribotoxin to a specific region on the ribosome, the SRL (Fig. 2, right panel).

Figure 1.

Figure 1

Homology of Argonaute (Ago2) to ribotoxin (restrictocin). A: Argonaute 2 (bovine, accession number NP_991363) and the ribotoxin protein restrictocin (accession number AAA32707) were manually aligned. Location of the ribotoxin loops and beta-strands are indicated above the restrictocin sequence. Dashes in the restrictocin sequence indicate amino acid segments present in the Argonaute protein (the number of aa is indicated in square brackets in the Argonaute protein) and absent from restrictocin. B: Conservation of lysine residues in Argonaute and restrictocin.

Figure 2.

Figure 2

Location of Ago sentinel loops homologous to the ribotoxin-restrictocin SRL-recognition loops on the Pyrococcus furiosus Argonaute protein. Left panel—Sentinel loops of the Ago protein (PDB: 1Z25) showing homology to ribotoxin loops are highlighted in dark blue and superimposed on the ribbon representation of the P. furiosus Ago protein [color scheme as in Ref. 18, N-terminal domain (blue), the “stalk” (light blue), the PAZ domain (red), the Mid domain (green), the PIWI domain (purple), and the interdomain connector (yellow)]. Homologous segments are indicated in the insets: identical amino acids and conserved substitutions are indicated by bold and regular red fonts, respectively. Right panel—Recognition of the SRL region of ribosomal RNA by the loop structures (indicated by dotted ovals) present on the ribotoxin protein (PDB: 1JBS).17 Note, the loop-recognition elements in the ribotoxin and the corresponding loops located in the Ago proteins (left panel), are indicated by red dashed ovals.

We observed similarities between restrictocin, a member of the ribotoxin family, and the Argonaute (Ago) proteins. A comparison of the restrictocin ribotoxin with bovine Ago2 is presented in Figure 1. Because of the high conservation of the amino acid sequence, similar results are obtained when the comparison is made with Agos1, 2, 3, and 4, both from murine and human origin. Moreover, other ribotoxins of the alpha-sarcin family also yield profiles similar to those of the Argonaute proteins.

Specifically, 48 amino acids (32%) of the restrictocin protein are identical with Ago2 [Fig. 1(A)]; allowing for conservative substitutions, this similarity increases to 65%. For each homologous tract, the similarity is localized predominantly in the restrictocin-specific sequences typically spanning seven or more amino acids. Examination of the ribotoxin and Argonaute proteins showed that the structure-breaking amino acids, proline and glycine, usually terminate the homologous regions [highlighted in Fig. 1(A) by double underline].

It bears mention that critical lysine residues present in both restrictocin and Argonaute proteins [Fig. 1(B)] are conserved in all human and mouse Argonaute proteins Agos1–4.

Ribotoxin loop 3 is especially pertinent to recognition of the SRL RNA structure. It includes the pentapeptide sequence DSKKP This sequence is critical to the interaction of the ribotoxin16 with a bulged-G motif7 within the SRL RNA structure, promoting specific binding and substrate cleavage. Indeed, mutations of the lysine residues in DSKKP so vital for SRL recognition, ablate ribotoxin translational inhibitory activity.16,17 It is thus striking that this string DSKKP is conserved in Ago proteins [Fig. 1(A,B)] as DGKKP [Fig. 1(B)] and that the extended 11 amino acid ribotoxin sequence 112YKFDSKKPKED appears within Pyrococcus furiosus Argonaute as 194FEEYTKKPKLD (Fig. 2, note ribotoxin FD appears in the reverse order in Pyrococcus as EY).

According to the three-dimensional structure determined by X-ray crystallography,18 it is clear that the Pyrococcus sequence KKPK is located strategically within a loop (Fig. 2) at the entrance to the groove, defined by the PAZ and PIWI domains, that can accommodate an RNA substrate. The KKPK motif present in loop 3 of the ribotoxins is essential to SRL binding by ribotoxins (Fig. 2, right panel). Another sentinel loop of the Pyrococcus Ago protein that guards entry into the cleft is located diagonally across the KKPK loop.

The extended sequence making-up this loop peptide is 581FDSQGYIRKI-VPIKIGEQRGE, similar to the restrictocin sequence 62YDGNGKLIKGRTPIKFGKADCD present in a large ribotoxin loop.

In addition, the Pyrococcus Ago protein consists of 614FNIKLDNKK that exhibits a marked similarity to the ribotoxin loop sequence 110HDYKFDSKK (Fig. 2). The sequence 614FNIK… appears within a loop on the same side as 581FDSQ.. and likely acts as an additional sentinel loop.

The most striking aspect of the protein sequence similarities between the alpha-sarcin-like ribotoxins and the Argonautes is that they are, as a rule, confined to the protein loop embellishments representing ribotoxin additions to the T1 RNAse skeleton (Figs. 1 and 2). These allow the ribotoxins to recognize SRL.

Intact “puromycin reactions” in translational suppression mediated by both alpha-sarcin-like ribotoxins and miRISCs

The mechanism of action mediated by miRISCs is unclear and there is a controversy as to which stage of protein synthesis, initiation19 or elongation,2025 is affected in miRISC-mediated translational repression. The latter carefully controlled and independently conducted studies showed that miRNAs and their translationally suppressed target mRNAs exist in polysomal configurations and suggest that elongation may also be one of the affected stages of protein synthesis.

Polysomes engaged in correctly functioning, uninhibited protein synthesis show an intact puromycin reaction wherein puromycin leads to polysomal dissociation. The intact puromycin reaction dictates the positioning of the peptidyl tRNA in the ribosomal P site, the sole location from which, following peptidyl-transferase activity, it can form the released peptidyl-puromycin moiety. Somewhat surprisingly, puromycin treatment of polysomes translationally suppressed by miRNA results in their dissociation.2325 This reflects an intact puromycin response and thus a correctly functioning translocation reaction in the miRNA-translationally suppressed system.

On the one hand, polysomal structures accompanying miRNA-mediated suppression of translation reflect a block in elongation and a defect at the elongation stage. On the other hand, the puromycin reaction seen in miRNA-mediated translational suppression intimates that elongation is, in fact, intact. This is because an intact puromycin reaction requires that both translocation and peptidyl transferase function correctly.

Translational suppression elicited by the ribotoxins exhibits the same paradox. Protein synthesizing systems inhibited by ribotoxins such as alpha sarcin26 are, like miRNA translational suppression, also accompanied by polysomal structures. This too indicates a defect occurring at the elongation stage.13,9 Here, as in miRNA-mediated translational repression, the puromycin reaction26 is intact, and reflects correct translocation and peptidyl-transferase activities.

Given the intact puromycin reaction, the only stage of elongation that could be affected by alpha sarcin is the binding of amino-acyl tRNA to the ribosomal A site.26 Subsequent experimental studies6,27 supported this conclusion and showed that alpha-sarcin cleaves a precise site within the large 28S rRNA component of the 60S in the Sarcin-Ricin-Loop. This represses translation by abrogating the binding of aminoacyl tRNA to the ribosomal A site.

Model for miRISC-mediated translational suppression

Translational suppression effected by the ribotoxin alpha-sarcin and miRNAs is extensively similar. Both undergo an intact puromycin reaction that is accompanied by blocks in elongation (described above). Moreover, the singular effector proteins of miRISCs are the Argonautes and these, like the ribotoxins, harbor protein domains with ribonuclease activity.

Furthermore, as we have shown here, the Ago proteins contain ribosomal-SRL-recognition segments similar to those appearing in ribotoxins. This suggests a similar function for these loops in directing the endoribonuclease component of the ribotoxin and the Argonaute proteins, to the SRL stem and loop structure. These findings indicate that the Argonautes may under certain conditions, such as miRISC translational suppression, mediate their inhibition by a mechanism similar to that used by ribotoxins, namely, cleavage of SRL (Fig. 3).

Figure 3.

Figure 3

Model for mechanism of action of miRNA-mediated translational suppression. (A) The miRISC composed of the Argonaute protein (green) the miRNA (red) and ancillary proteins such as GW182 forms incompletely base-paired duplexes at 3′ UTR target sequences on discrete mRNAs (the curved blue line); (B and C) The Ago protein (green) in conjunction with the miRNA component (red line) recognizes and binds to a critical target site designated the SRL (enclosed by the dotted rectangle and enlarged in the inset) on the rRNA component of the large ribosome subunit. This is illustrated by the black “squiggly” line appearing on the large ribosomal subunit (pink oval). (D) The Ago protein associated with miRISC, after verging on its rRNA target site, cleaves the ribosomal RNA (cleavage indicated within the dotted red oval), thereby leading to disruption of protein synthesis: the miRISC translational suppression.

Cumulatively, our results suggest the following (Fig. 3): (a) the miRISC forms incompletely base-paired duplexes at 3′ UTR target sequences on discrete mRNAs; (b and c) the Ago proteins in conjunction with the miRNA component recognize and bind to a critical target site on the RNA component of the large ribosomal subunit, (d) the Ago protein associated with miRISC, after verging on the rRNA target site on the ribosome, cleaves the ribosomal RNA, thereby disrupting protein synthesis—the miRISC translational suppression.

Although there is no mRNA degradation associated with miRISC suppression, endoribonucleolytic activity is retained in the Ago effector proteins of the miRISC complexes. This is probably mandatory for rRNA cleavage. In this context, it should be noted that whereas Ago proteins Ago1 through Ago4 are competent for miRNA-mediated translational suppression, mouse Ago5 does not support such suppression.28 Accordingly, mAgo5 alone lacks Ago sequences28 similar to those in the restrictocin loop4-β6-loop5 [Fig. 1(B)].

Finally, localization of miRISC complexes in the 3′UTR,25 and not in coding sequences directly adjacent to the ribosomes, allows the complex, because of spatial considerations, to flip back and bind to the most distal 3′ ribosome. There the complex executes the cleavage and halts the ribosome in its progression on mRNA. This, in turn, stalls the more 5′ proximal ribosomes, leading to translational suppression (Fig. 3).

Polysomes translationally suppressed by miRNAs are obviously present at levels far lower than those of translationally intact polysomes, making it unlikely that the total cellular translational apparatus would be inactivated by miRISC-targeted ribosomes. In this context, it is notable that the endoribonuclease activity of the Ago proteins leaves behind 5′-phosphate and 3′-hydroxyl termini, rendering an Ago-cleaved SRL amenable to repair at later stages by the appropriate ligases and resulting in the restoration of a translationally competent ribosome.

In addition to the α-sarcin-like ribotoxins, the potent plant toxin ricin also represses translation by eliciting changes within the SRL site: it depurinates the A4324 residue immediately upstream of the site of α-sarcin mediated cleavage.5 Shiga toxins made by Shiga toxin-producing Escherichia coli also target the same site and suppress translation in a similar fashion to ricin.29,30 Nature has found it expedient in all these cases, in toxins derived from plants (ricin-like proteins), fungi (α-sarcin-like proteins), and bacteria (Shiga-like toxins), to target the exact same 28S rRNA region to suppress translation. Furthermore, translational suppression elicited by certain bacterial colicins is also mediated by specific ribosomal RNA cleavage, albeit on the 16 rRNA component.31 Additionally, specific cleavages on ribosomal RNA accompanying translational suppression have been documented in interferon-treated and virally infected cells.32,33

In summary, our studies reveal protein sequence similarities between two apparently disparate protein families: the alpha-sarcin-like ribotoxins and the major constituents of RNA-induced silencing complexes, the Argonautes. The homology resides in protein loops that provide the ribotoxins with specificity for the Sarcin-Ricin-Loop, suggesting that similar segments in the Argonautes also target the SRL. Moreover, suppression of translation in systems inhibited by either miRISCs or ribotoxins is accompanied by both intact polysomes and a puromycin reaction that is uniquely unharmed. These findings support a mechanism for miRNA-mediated translational suppression whereby regulated cleavage of ribosomal RNA leads to translational suppression (Fig. 3), probably mimicking a more widespread means found in Nature.

Materials and Methods

Representatives of the alpha-sarcin-like ribotoxin family, restrictocin (accession number AAA32707, see Fig. 1) and alpha-sarcin, were subjected to a ClustalW analysis against Ago proteins from diverse organisms. These included Ago2 from Bos taurus (accession number NP_991363, Fig. 1), Agos1–4 from Homo sapiens, Agos1–5 from Mus musculus as well as the Argonaute protein from Pyrococcus furiosus. The sequences were subsequently manually aligned according to the initial ClustalW analysis. The amino acid sequences from restrictocin showing similarity to the Ago proteins were located on the Argonaute protein from Pyrococcus furiosus.18

Acknowledgments

Part of this research was supported by Grant 20100090 from the Israel Cancer Association.

References

  • 1.Lamy B, Davies J, Schindler D. The Aspergillus ribonucleolytic toxins (ribotoxins) Targeted Diagn Ther. 1992;7:237–258. [PubMed] [Google Scholar]
  • 2.Schindler DG, Davies JE. Specific cleavage of ribosomal RNA caused by alpha sarcin. Nucleic Acids Res. 1977;4:1097–1110. doi: 10.1093/nar/4.4.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Endo Y, Wool IG. The site of action of alpha-sarcin on eukaryotic ribosomes. The sequence at the alpha-sarcin cleavage site in 28 S ribosomal ribonucleic acid. J Biol Chem. 1982;257:9054–9060. [PubMed] [Google Scholar]
  • 4.Endo Y, Mitsui K, Motizuki M, Tsurugi K. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem. 1987;262:5908–5912. [PubMed] [Google Scholar]
  • 5.Endo Y, Tsurugi K. RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J Biol Chem. 1987;262:8128–8130. [PubMed] [Google Scholar]
  • 6.Endo Y, Huber PW, Wool IG. The ribonuclease activity of the cytotoxin alpha-sarcin. The characteristics of the enzymatic activity of alpha-sarcin with ribosomes and ribonucleic acids as substrates. J Biol Chem. 1983;258:2662–2667. [PubMed] [Google Scholar]
  • 7.Gluck A, Wool IG. Determination of the 28 S ribosomal RNA identity element (G4319) for alpha-sarcin and the relationship of recognition to the selection of the catalytic site. J Mol Biol. 1996;256:838–848. doi: 10.1006/jmbi.1996.0130. [DOI] [PubMed] [Google Scholar]
  • 8.Gluck A, Wool IG. Analysis by systematic deletion of amino acids of the action of the ribotoxin restrictocin. Biochim Biophys Acta. 2002;1594:115–126. doi: 10.1016/s0167-4838(01)00290-4. [DOI] [PubMed] [Google Scholar]
  • 9.Wool IG, Gluck A, Endo Y. Ribotoxin recognition of ribosomal RNA and a proposal for the mechanism of translocation. Trends Biochem Sci. 1992;17:266–269. doi: 10.1016/0968-0004(92)90407-z. [DOI] [PubMed] [Google Scholar]
  • 10.Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102–114. doi: 10.1038/nrg2290. [DOI] [PubMed] [Google Scholar]
  • 11.Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell. 2009;136:642–655. doi: 10.1016/j.cell.2009.01.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hutvagner G, Simard MJ. Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol. 2008;9:22–32. doi: 10.1038/nrm2321. [DOI] [PubMed] [Google Scholar]
  • 13.Liu J, et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science. 2004;305:1437–1441. doi: 10.1126/science.1102513. [DOI] [PubMed] [Google Scholar]
  • 14.Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 2000;101:25–33. doi: 10.1016/S0092-8674(00)80620-0. [DOI] [PubMed] [Google Scholar]
  • 15.Wang B, Li S, Qi HH, Chowdhury D, Shi Y, Novina CD. Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins. Nat Struct Mol Biol. 2009;16:1259–1266. doi: 10.1038/nsmb.1712. [DOI] [PubMed] [Google Scholar]
  • 16.Kao R, Davies J. Molecular dissection of mitogillin reveals that the fungal ribotoxins are a family of natural genetically engineered ribonucleases. J Biol Chem. 1999;274:12576–12582. doi: 10.1074/jbc.274.18.12576. [DOI] [PubMed] [Google Scholar]
  • 17.Yang X, Gerczei T, Glover LT, Correll CC. Crystal structures of restrictocin-inhibitor complexes with implications for RNA recognition and base flipping. Nat Struct Biol. 2001;8:968–973. doi: 10.1038/nsb1101-968. [DOI] [PubMed] [Google Scholar]
  • 18.Song JJ, Smith SK, Hannon GJ, Joshua-Tor L. Crystal structure of argonaute and its implications for RISC slicer activity. Science. 2004;305:1434–1437. doi: 10.1126/science.1102514. [DOI] [PubMed] [Google Scholar]
  • 19.Wang B, Yanez A, Novina CD. MicroRNA-repressed mRNAs contain 40S but not 60S components. Proc Natl Acad Sci USA. 2008;105:5343–5348. doi: 10.1073/pnas.0801102105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Seggerson K, Tiang L, Moss EG. Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev Biol. 2002;243:215–225. doi: 10.1006/dbio.2001.0563. [DOI] [PubMed] [Google Scholar]
  • 21.Olsen PH, Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol. 1999;216:671–680. doi: 10.1006/dbio.1999.9523. [DOI] [PubMed] [Google Scholar]
  • 22.Maroney PA, Yu Y, Fisher J, Nilsen TW. Evidence that microRNAs are associated with translating messenger RNAs in human cells. Nat Struct Mol Biol. 2006;13:1102–1107. doi: 10.1038/nsmb1174. [DOI] [PubMed] [Google Scholar]
  • 23.Nottrott S, Simard MJ, Richter JD. Human let-7a miRNA blocks protein production on actively translating polyribosomes. Nat Struct Mol Biol. 2006;13:1108–1114. doi: 10.1038/nsmb1173. [DOI] [PubMed] [Google Scholar]
  • 24.Petersen CP, Bordeleau ME, Pelletier J, Sharp PA. Short RNAs repress translation after initiation in mammalian cells. Mol Cell. 2006;21:533–542. doi: 10.1016/j.molcel.2006.01.031. [DOI] [PubMed] [Google Scholar]
  • 25.Gu S, Jin L, Zhang F, Sarnow P, Kay MA. Biological basis for restriction of microRNA targets to the 3′ untranslated region in mammalian mRNAs. Nat Struct Mol Biol. 2009;16:144–150. doi: 10.1038/nsmb.1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hobden AN, Cundliffe E. The mode of action of alpha sarcin and a novel assay of the puromycin reaction. Biochem J. 1978;170:57–61. doi: 10.1042/bj1700057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Brigotti M, Rambelli F, Zamboni M, Montanaro L, Sperti S. Effect of alpha-sarcin and ribosome-inactivating proteins on the interaction of elongation factors with ribosomes. Biochem J. 1989;257:723–727. doi: 10.1042/bj2570723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Su H, Trombly MI, Chen J, Wang X. Essential and overlapping functions for mammalian argonautes in microRNA silencing. Genes Dev. 2009;23:304–317. doi: 10.1101/gad.1749809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem. 1988;171:45–50. doi: 10.1111/j.1432-1033.1988.tb13756.x. [DOI] [PubMed] [Google Scholar]
  • 30.Saxena SK, O'Brien AD, Ackerman EJ. Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J Biol Chem. 1989;264:596–601. [PubMed] [Google Scholar]
  • 31.Bowman CM, Dahlberg JE, Ikemura T, Konisky J, Nomura M. Specific inactivation of 16S ribosomal RNA induced by colicin E3 in vivo. Proc Natl Acad Sci USA. 1971;68:964–968. doi: 10.1073/pnas.68.5.964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wreschner DH, James TC, Silverman RH, Kerr IM. Ribosomal RNA cleavage, nuclease activation and 2–5A(ppp(A2′p)nA) in interferon-treated cells. Nucleic Acids Res. 1981;9:1571–1581. doi: 10.1093/nar/9.7.1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wreschner DH, McCauley JW, Skehel JJ, Kerr IM. Interferon action—sequence specificity of the ppp(A2′p)nA-dependent ribonuclease. Nature. 1981;289:414–417. doi: 10.1038/289414a0. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES